Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01129167 · ClinicalTrials.gov registry record

Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma

A clinical trial, sponsored by Columbia University.

Completed
Registry status
1,052
Enrollment target

NCT01129167 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 1,052 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01129167 has completed, sponsored by Columbia University.

COMPLETED
Registry status
1,052 participants
Enrollment target

Study Summary

Pancreatic cancer often spreads through local invasion into local structures, including fat, blood vessels, nerves, and nearby organs (stomach, duodenum, spleen, bile duct). Local microscopic invasion is associated with recurrence of pancreatic cancer after pancreatic resection, such that even if the original cancer is surgically removed, microscopic areas of cancer often remain. Data on the patterns of local invasion by pancreatic cancer have not been published. In this study, The investigators hope to investigate the frequency of the various methods of local invasion of pancreatic adenocarcinoma. This would help the investigators better understand how pancreatic cancer spreads, and determine what cancers are not resectable.

Trial Details

FieldValue
Enrollment Target 1,052 participants
Start Date 2009-09-15
Est. Completion 2022-09-30

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT01129167

The ClinicalTrials.gov registry entry for NCT01129167 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,052 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01129167 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01129167 about?

NCT01129167 is a clinical study titled "Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma". Pancreatic cancer often spreads through local invasion into local structures, including fat, blood vessels, nerves, and nearby organs (stomach, duodenum, spleen, bile duct). Local microscopic invasion is associated with recurrence of pancreatic cancer after pancreatic resection, such that even if th...

What is the current status of trial NCT01129167?

This trial is currently completed. The enrollment target is 1,052 participants. The study started on 2009-09-15. Estimated completion is 2022-09-30.

Who is sponsoring clinical trial NCT01129167?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.